Konstantina Strongili

Statistics

Publications

Citations

589

H-Index

Active since

2019

Affiliations

Cambridge University Hospitals NHS Foundation Trust(Current)

University of Cambridge

Wellcome Sanger Institute

Barts Health NHS Trust

University of Exeter

Konstantina Strongili is an author at Cambridge University Hospitals NHS Foundation Trust specializing in inflammatory bowel disease, gastrointestinal inflammation, and inflammation.

Publications per year

2019–2022

Publications

Anti-commensal IgG Drives Intestinal Inflammation and Type 17 Immunity in Ulcerative Colitis

Tomas Castro‐Dopico, Thomas W. Dennison, John R. Ferdinand et al. · Immunity · 2019 · 239 citations · Full text

Life Sciences, Immunology, Pathology +16

Somatic Evolution in Non-neoplastic IBD-Affected Colon

Sigurgeir Ólafsson, Rebecca E. McIntyre, Tim Coorens et al. · Cell · 2020 · 206 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab

Simeng Lin, Nicholas A. Kennedy, Aamir Saifuddin et al. · Nature Communications · 2022 · 81 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Zhigang Liu, Kaixing Le, Xin Zhou et al. · The Lancet. Gastroenterology & hepatology · 2022 · 35 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Somatic evolution in non-neoplastic IBD-affected colon

Sigurgeir Ólafsson, Rebecca E. McIntyre, Tim Coorens et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2019 · 28 citations · Full text

Medicine, Genetics, Molecular Genetics +17

1–5 of 5